| 000 | 01023 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514015000.0 | ||
| 264 | 0 | _c20020322 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0012-6667 | ||
| 024 | 7 |
_a10.2165/00003495-200161120-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabianca, R F | |
| 245 | 0 | 0 |
_aDisease management considerations: disease management considerations. _h[electronic resource] |
| 260 |
_bDrugs _c2001 |
||
| 300 |
_a1751-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xphysiopathology |
| 700 | 1 | _aBeretta, G D | |
| 700 | 1 | _aPessi, M A | |
| 773 | 0 |
_tDrugs _gvol. 61 _gno. 12 _gp. 1751-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-200161120-00006 _zAvailable from publisher's website |
| 999 |
_c11609146 _d11609146 |
||